Module 6: Good Laboratory Practice (RAPM58619)

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/199

flashcard set

Earn XP

Description and Tags

Comprehensive set of 200 vocabulary flashcards covering Module 6 on Good Laboratory Practice (GLP), the OECD framework, facility roles, study documentation, and compliance monitoring systems.

200 Terms

1
New cards

Module 6

The specific instructional module within RAPM58619 dedicated to the principles and implementation of Good Laboratory Practice (GLP).

2
New cards

RAPM58619

The course code designated for Principles of Good Practices GxP, covering OECD Good Laboratory Practice and compliance monitoring systems.

3
New cards

Good Laboratory Practice (GLP)

The organizational process and conditions under which non-clinical health and environmental safety studies are planned, performed, monitored, recorded, archived, and reported.

4
New cards

Non-Clinical Studies

Experiments conducted under laboratory conditions to determine the safety or tolerability of test items, excluding studies utilizing human subjects or clinical studies in animals.

5
New cards

Tolerability

A primary parameter evaluated in non-clinical laboratory experiments to assess how well a biological test system sustains exposure to a test item without excessive adverse effects.

6
New cards

Safety (in Non-Clinical Testing)

The hazard and risk profile determined through controlled laboratory, greenhouse, or field non-clinical studies under GLP.

7
New cards

Clinical Studies

Investigations involving human subjects or clinical studies in animals, which are explicitly excluded from the scope of OECD GLP Principles.

8
New cards

Organization for Economic Cooperation and Development (OECD)

An international organization comprising 38 member countries and 5 partners that establishes international standards and fosters collaboration on global issues.

9
New cards

Organization for European Economic Co-operation (OECC)

The predecessor body to the OECD, founded in 1948 to administer economic aid following World War II.

10
New cards

1948 (OECC Founding)

The year the Organization for European Economic Co-operation (OECC) was established to administer aid after WWII.

11
New cards

1962 (OECD Transition)

The year the Organization for European Economic Co-operation (OECC) officially transitioned and became the OECD.

12
New cards

OECD Member Countries

The 38 sovereign nations, including Canada, that comprise the OECD and agree to uphold its established international guidelines.

13
New cards

OECD Partner Countries

The 5 global partner economies that collaborate with the OECD on international standards and policy initiatives alongside member nations.

14
New cards

Inform & Advise

An OECD main function focused on providing socio-economic data and analytical insights to policy makers and researchers.

15
New cards

Engage & Influence

An OECD main function that brings policy makers and policy experts together to exchange ideas and develop public policies.

16
New cards

Set Standards and Provide Policy Support

An OECD main function dedicated to developing internationally agreed standards to ensure all member nations adhere to similar rules.

17
New cards

Socio-Economic Data and Analysis

Quantitative and qualitative research compiled under the OECD's 'Inform & Advise' mandate to guide policy decisions.

18
New cards

1981 (OECD GLP Adoption)

The year the Principles of Good Laboratory Practice were formally adopted by the OECD Council, with participation from countries including Canada.

19
New cards

Harmonization of Test Methods

The international alignment of testing protocols and GLP principles to prevent duplicative animal and chemical safety testing across nations.

20
New cards

Duplicative Testing

Redundant safety testing carried out in multiple jurisdictions, which OECD GLP harmonization aims to eliminate.

21
New cards

Mutual Acceptance of Data (MAD)

The OECD principle establishing that non-clinical safety data generated in an OECD member state in accordance with GLP will be accepted by other member countries.

22
New cards

1997 (Revised GLP Adoption)

The year the OECD Council formally adopted the updated and Revised Principles of Good Laboratory Practice.

23
New cards

OECD Document No. 1

The official document in the OECD Series on Principles of GLP and Compliance Monitoring titled 'OECD Principles on Good Laboratory Practice' (env/mc/chem(98)17).

24
New cards

OECD Document No. 2

The official document in the OECD Series on Principles of GLP and Compliance Monitoring titled 'Revised Guides for Compliance Monitoring Procedures for Good Laboratory Practice' (ocde/gd(95)66).

25
New cards

Non-Clinical Safety Studies

Controlled experimental evaluations carried out by test facilities to evaluate the health and environmental safety profiles of regulated items.

26
New cards

Pharmaceutical Products (GLP Scope)

Human medicinal drug products whose non-clinical safety and tolerability testing must be conducted in compliance with GLP.

27
New cards

Pesticide Products (GLP Scope)

Agrochemical and pest control substances whose non-clinical safety data must be generated in adherence to GLP standards.

28
New cards

Cosmetic Products (GLP Scope)

Personal care and cosmetic substances whose non-clinical safety evaluations fall under the regulatory applicability of GLP.

29
New cards

Veterinary Drugs (GLP Scope)

Therapeutic products intended for animal administration that require non-clinical safety studies executed following GLP.

30
New cards

Food and Feed Additives (GLP Scope)

Direct substances or supplements introduced into food or animal feed that require GLP-compliant non-clinical safety testing.

31
New cards

Industrial Chemicals (GLP Scope)

Commercial chemical agents and bulk substances whose health and environmental safety data must be established under GLP.

32
New cards

Greenhouses (GLP Testing Site)

Enclosed, controlled plant growth environments recognized under GLP as valid testing locations for non-clinical studies.

33
New cards

Field Studies (GLP Testing Site)

Outdoor or agricultural experimental environments outside traditional laboratories where non-clinical safety studies are conducted under GLP.

34
New cards

Test Facility

The organizational entity encompassing personnel, premises, and operational units required for carrying out non-clinical safety studies.

35
New cards

Test Facility Management

The person or persons having the formal authority and responsibility for the organization and functioning of the test facility.

36
New cards

Formal Responsibility and Authority (Management)

The executive mandate vested in test facility management to direct operations, allocate resources, and ensure total GLP compliance.

37
New cards

Personnel Sufficiency

The requirement that test facility management ensure a sufficient number of personnel are available to perform all study functions.

38
New cards

Personnel Qualifications and Training Records

Curated files maintained by management containing records of qualifications, training, experience, and job descriptions for all facility staff.

39
New cards

Job Description (GLP)

A documented outline maintained for each individual in a test facility specifying their defined functions, roles, and responsibilities.

40
New cards

Facility Resource Allocation

The management duty to ensure that appropriate facilities, equipment, and materials are available for the conduct of studies.

41
New cards

Documented Study Plan Approval (Management Duty)

A key management responsibility to ensure that the study plan receives formal, documented approval by the Study Director prior to study initiation.

42
New cards

Master Schedule

A comprehensive tracking system maintained by test facility management to compile study timelines, track active studies, and assess facility workload.

43
New cards

Master Schedule Maintenance

The active administrative responsibility of test facility management to keep the central schedule of all studies up to date.

44
New cards

Test and Reference Items Inventory

A documented management system ensuring that test and reference items are appropriately logged, tracked, and stored within the facility.

45
New cards

Computer Systems Suitability

The management requirement ensuring that all computer systems used in non-clinical studies are appropriate and fit for their intended purpose.

46
New cards

Computer Systems Validation

The documented process established by management to ensure computer systems operate reliably, accurately, and in compliance with GLP.

47
New cards

Computer Systems Operation and Maintenance

Procedures established by management ensuring computer systems are operated and maintained in strict accordance with GLP.

48
New cards

Standard Operating Procedures (SOPs)

Written, management-approved procedures outlining how routine laboratory, administrative, and testing operations must be executed.

49
New cards

Approval of Original SOPs

The formal responsibility of test facility management to evaluate, approve, and sign all newly created Standard Operating Procedures.

50
New cards

Approval of Revised SOPs

The mandatory endorsement required from test facility management to validate any changes or updates made to existing SOPs.

51
New cards

Study Director

The single point of study control who has the responsibility for the overall conduct of the study and for its final report.

52
New cards

Single Point of Study Control

The regulatory concept designating the Study Director as the central individual with sole responsibility for the entire study.

53
New cards

Overall Conduct of the Study

The technical, scientific, and administrative execution of a non-clinical study, which falls entirely under the Study Director's accountability.

54
New cards

Final Report Responsibility (Study Director)

The obligation of the Study Director to oversee, compile, validate, sign, and date the final study report.

55
New cards

Study Plan Approval (Study Director)

The formal signing and dating of the written study plan by the Study Director prior to starting experimental activities.

56
New cards

Study Plan Amendments Approval

The Study Director's duty to formally review, justify, approve, and sign any modifications made to an approved study plan.

57
New cards

Communication with Quality Assurance (Study Director)

The requirement for the Study Director to communicate effectively with QA personnel and ensure they possess an approved copy of the study plan.

58
New cards

SOP Availability (Study Director Duty)

The Study Director's responsibility to make all approved study plans and relevant SOPs readily accessible to study personnel.

59
New cards

Multi-Site Study

A study conducted across multiple test facilities or test sites, requiring coordination between the Study Director and Principal Investigators.

60
New cards

Test Site

A distinct location or external facility where specific delegated phases of a multi-site study are performed.

61
New cards

Principal Investigator (PI)

An individual who, for a multi-site study, acts on behalf of the Study Director and has defined responsibilities for delegated phases of the study.

62
New cards

Delegated Phases of the Study

Specific experimental, operational, or analytical segments of a multi-site study assigned to a Principal Investigator at a remote test site.

63
New cards

Non-Delegable Responsibilities (Study Director)

Core duties that cannot be delegated to a PI, including approval of study plans/amendments, signing final reports, and overall GLP compliance.

64
New cards

Study Plan Adherence (Study Director)

The Study Director's duty to verify that all study personnel follow the approved study plan throughout the study.

65
New cards

Assessment of Study Plan Deviations

The scientific evaluation conducted by the Study Director to determine how unintended departures from the protocol affect study validity.

66
New cards

Documentation of Deviations (Study Director)

The formal recording and explanation of any deviations from the study plan performed by the Study Director.

67
New cards

Corrective Actions (Study Director)

Remedial procedures designed and implemented by the Study Director to correct study plan deviations when necessary.

68
New cards

Raw Data Recording (Study Director Duty)

The Study Director's obligation to ensure that all raw data generated during an experiment is fully recorded and documented.

69
New cards

Computerized Systems Validation Verification (Study Director)

The Study Director's responsibility to confirm that all computerized systems utilized during the study have been validated.

70
New cards

Final Report Sign-Off (Study Director)

The requirement that the Study Director sign and date the final report to indicate the validity of the data.

71
New cards

Indication of GLP Compliance Extent

A formal statement signed by the Study Director in the final report declaring the extent to which the study complies with GLP.

72
New cards

Post-Study Archiving (Study Director Duty)

The Study Director's responsibility to archive the study plan, final report, raw data, and supporting material after study completion.

73
New cards

Supporting Material Archiving

The secure transfer and preservation of physical specimens, samples, and documentation to the facility archives following study completion.

74
New cards

Principal Investigator GLP Compliance

The duty of a Principal Investigator to ensure that all delegated phases of a multi-site study under their supervision comply with GLP.

75
New cards

Study Personnel

Laboratory technicians, scientists, and operational staff directly engaged in executing the procedures of a non-clinical study.

76
New cards

Study Personnel SOP Compliance

The obligation of technical staff to comply strictly with all applicable study plans and Standard Operating Procedures.

77
New cards

Personnel Deviation Communication

The mandatory requirement that study personnel document deviations and communicate them immediately to the Study Director or PI.

78
New cards

Prompt Raw Data Recording

The GLP requirement that study personnel record raw experimental observations promptly at the time of execution.

79
New cards

Accurate Raw Data Recording

The obligation of study personnel to document laboratory data accurately, completely, and in accordance with GLP.

80
New cards

Health Precautions (Study Personnel)

Protective measures and occupational hygiene protocols taken by study personnel to minimize risks and ensure study integrity.

81
New cards

Health and Medical Condition Reporting

The requirement that study personnel communicate any relevant health or medical condition that could compromise the study.

82
New cards

Study Integrity

The complete scientific validity, authenticity, and untainted status of experimental results and biological systems in a study.

83
New cards

Quality Assurance (QA) Program

A documented program required to assure that non-clinical studies are performed in compliance with GLP.

84
New cards

Documented QA Program

Written policies, inspection procedures, and audit schedules defining the operational execution of Quality Assurance in a facility.

85
New cards

Quality Assurance Personnel

Personnel familiar with test procedures who are designated by and directly responsible to management to monitor GLP compliance.

86
New cards

QA Familiarity with Test Procedures

The prerequisite technical knowledge Quality Assurance personnel must possess regarding test methods to audit studies effectively.

87
New cards

Direct Responsibility to Management (QA)

The reporting structure whereby Quality Assurance personnel report directly to facility management rather than study staff.

88
New cards

QA Independence from Study Conduct

The GLP rule establishing that Quality Assurance personnel should not be involved in the actual conduct of the study.

89
New cards

QA Access to Master Schedule

The entitlement and operational requirement for QA personnel to maintain access to the facility master schedule.

90
New cards

Study Plan GLP Verification (QA)

The formal review conducted by QA personnel to verify and document that a written study plan complies with GLP principles.

91
New cards

Study Inspections (QA)

Periodic examinations performed by QA personnel to verify that study conduct and facility operations comply with GLP.

92
New cards

Retention of Inspection Records (QA)

The mandatory preservation of audit logs, findings, and checklists generated by QA personnel during facility and study inspections.

93
New cards

Prompt Reporting of Inspection Results (QA)

The requirement that QA personnel promptly report all inspection findings in writing to management and the Study Director.

94
New cards

QA Statement (Final Report)

A formal statement prepared and signed by QA for the final report detailing inspection information, inspection dates, and data verification.

95
New cards

QA Inspection Dates Reporting

Detailed calendar information on all study inspections that QA personnel must include within the final report's QA statement.

96
New cards

Review of Final Reports (QA)

The Quality Assurance audit verifying that the final report accurately and completely reflects the study raw data.

97
New cards

Facility Size, Construction, and Location

Physical requirements mandating that test facilities have a suitable size, construction, and location to meet the requirements of the study.

98
New cards

Separation of Activities (Facilities)

The architectural provision of a sufficient number of rooms or areas to separate distinct activities and prevent mix-ups.

99
New cards

Biohazardous Substances Isolation

The structural isolation of facility rooms and test systems involving biohazardous substances to prevent contamination.

100
New cards

Storage Rooms for Supplies and Equipment

Dedicated rooms or areas within a test facility allocated for the secure storage of operational supplies and equipment.